Release date: 2010-05-25

India Private Investments Scaling Up in Clinical Trial Industry Finds

(Newswire Today) —  Noida, Uttar Pradesh, India, 2010-05-25 - The increasing private investments in the clinical trial facilities are expected to drive the future growth of the Indian clinical trial industry, says RNCOS in its new research.


Clinical trials are considered as one of the most important stages of the drug development and share a major part of the cost and time involved in the whole process. With an increasing pressure on pharmaceutical and biotech companies to increase their product pipelines and at the same time to reduce the cost involved in drug development, multinational pharmaceutical companies have started outsourcing clinical trials to emerging healthcare markets like India. RNCOS, a leading market research firm, says in its new report “Booming Clinical Trials Market in India” that India has tremendous potential to attract multinationals to invest in its clinical trials market. The market is expected to grow at a CAGR of around 31% during 2010-2012.

With the increasing trend of outsourcing clinical trials, the private investments in the sector have also increased. Most of these investments are aimed at setting up clinical trial facilities in the country. Also, it has been observed that some multinationals have made joint ventures with the Indian companies to set up such facilities. In this regard, our research report provides complete information on the current scenario of the Indian clinical trial industry.

One of the other major advantages that India has, is the availability of large patient pool. The prevalence of diseases, like CVD, diabetes and cancer, is very high in the country, and this makes the availability and administration of patients for clinical trials very easy. Our research provides a thorough study and analysis of the Indian clinical trial industry. Besides, the report has also highlighted the importance of cost factor in the development of the industry and it provides complete details of the cost involved in various phases of clinical trials in the country.

“Booming Clinical Trials Market in India” gives a comprehensive review of the Indian clinical trial industry. Thorough evaluation of current trends and developments vital for the success of Indian clinical trials market has been done. The report also covers information on various major players present in the market. The report will prove to be a useful investment guide for our clients who are looking forward to invest in the market.



RNCOS (, incorporated in the year 2002, is an industry research firm. We are a team of industry experts who analyze data collected from credible sources. We provide industry insights and analysis that helps corporations to take timely and accurate business decision in today's globally competitive environment.


Agency / Source:

# # #
  Related Link:
 Contact name: Shushmul Maheshwari -
  Related Link:
 +91 12 04224700 / press[.]
PRZOOM disclaims any content contained in these release. Our complete disclaimer appears on our disclaimer page. Issuers of releases are solely responsible for the accuracy of their content. All trademarks are the property of their respective owners.
© - - Press Release & Newswire Distribution Network.

Boost Your Social Network
& Crowdfunding Campaigns

NewswireToday Celebrates 10 Years in Business




  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (